OTI Lumionics Releases Breakthrough Algorithms for Quantum Chemistry Simulations

OTI Lumionics, a leader in advanced quantum simulations and solutions for next-generation materials discovery, announces the publication of its scientific paper, “Optimization of the Qubit Coupled Cluster Ansatz on classical computers,” in the Journal of Chemical Theory and Computation (JCTC). The results mark a major advancement in the quantum computing and OLED industry, demonstrating that large-scale quantum simulations of materials can be simulated today on classical hardware with high-accuracy results. Historically, current quantum computers have struggled to achieve this capability.

XGS Energy and Meta to Partner on 150 MW Advanced Geothermal Project

XGS Energy, Inc. (XGS) and Meta Platforms, Inc (Meta) today announced an agreement to support development of 150 MW of next-generation geothermal energy in New Mexico, highlighting the critical role XGS will play in rapidly delivering reliable electricity to meet growing energy demand.

AM Batteries Opens Doors to Customers, Expediting Electrode Sales for Next Generation Batteries

AM Batteries, a pioneer in dry battery electrode (DBE) technology, opened its state-of-the-art Customer Success Center Monday, enabling the development of next-generation batteries with advanced manufacturing technology. AM Batteries’ new facility will play a crucial role in ongoing efforts to secure the U.S. battery manufacturing supply chain. The ribbon-cutting ceremony was attended by U.S. Representative Lori Trahan (D-MA) and Massachusetts’ Interim Secretary of Economic Development Ashley Stolba.

EnCharge AI Announces EN100, First-of-its-Kind AI Accelerator for On-Device Computing

EnCharge AI today announced the EnCharge EN100, the industry’s first AI accelerator built on precise and scalable analog in-memory computing. Designed to bring advanced AI capabilities to laptops, workstations, and edge devices, EN100 leverages transformational efficiency to deliver 200+ TOPS of total compute power within the power constraints of edge and client platforms such as laptops.

Excision BioTherapeutics Presents Data from HBV and HSV Programs at the ASGCT 2025 Annual Meeting

Excision BioTherapeutics, Inc. (“Excision” or the “Company”), a biotechnology company developing CRISPR-based therapies to cure viral infectious diseases, today announced new data presentations from its preclinical programs, hepatitis B virus (HBV), EBT-107 and herpes simplex virus (HSV-1) keratitis, EBT-104 at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, taking place May 13–17 in New Orleans, Louisiana.

CytoTronics Expands Pixel Capability with Multi-modal Cardiac Application for Early Screening of Drug Candidates in Cardiovascular Research

CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, launched their novel Cardiac application today—the next key offering in its Pixel application portfolio. The first-of-its-kind, multi-modal application lets drug discovery scientists focused on cardiovascular disease and cardiotoxicology measure the electrical activity, contractility and structure of cardiomyocytes in a single assay at scale in 96-and 384-well plates.